Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Epoprostenol MeSH Descriptor Data 2026


MeSH Heading
Epoprostenol
Tree Number(s)
D10.251.355.255.550.550.500
D23.469.050.175.725.550.500
Unique ID
D011464
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D011464
Scope Note
A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Entry Term(s)
Epoprostanol
Epoprostenol Sodium
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
Flolan
Prostacyclin
Prostaglandin I(2)
Prostaglandin I2
Veletri
Pharm Action
Antihypertensive Agents
Platelet Aggregation Inhibitors
Registry Numbers
DCR9Z582X0
4K04IQ1OF4
0
Related Numbers
35121-78-9
4K04IQ1OF4
CAS Type 1 Name
Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-
Previous Indexing
Prostaglandins (1966-1977)
Public MeSH Note
1991; see PROSTAGLANDINS X 1978-1990; for PROSTACYCLIN see PROSTACYCLINS 1978-1993; for PROSTAGLANDIN I2 see PROSTAGLANDINS I2 1982-1993; for PROSTAGLANDIN X see PROSTAGLANDINS X 1991-1993
History Note
1991 (1978); use PROSTAGLANDINS X 1978-1990; for PROSTACYCLIN use PROSTACYCLINS 1978-1993; for PROSTAGLANDIN I2 use PROSTAGLANDINS I2 1982-1993; for PROSTAGLANDIN X use PROSTAGLANDINS X 1991-1993
Date Introduced
1984/01/01
Last Updated
2018/03/01
Epoprostenol Preferred
Epoprostenol Sodium Narrower
Flolan Narrower
Veletri Narrower
page delivered in 0.114s